IMAB Old Valuation
| IMABDelisted Stock | USD 3.98 0.02 0.51% |
At this time, the firm appears to be fairly valued. IMAB Old owns a latest Real Value of $3.85 per share. The recent price of the firm is $3.98. Our model calculates the value of IMAB Old from examining the firm fundamentals such as Return On Asset of -0.1, shares outstanding of 115.27 M, and Shares Owned By Insiders of 21.39 % as well as evaluating its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that IMAB Old's price fluctuation is relatively risky at this time. Calculation of the real value of IMAB Old is based on 3 months time horizon. Increasing IMAB Old's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since IMAB Old is currently traded on the exchange, buyers and sellers on that exchange determine the market value of IMAB Stock. However, IMAB Old's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.98 | Real 3.85 | Hype 3.92 | Naive 4.25 |
The real value of IMAB Stock, also known as its intrinsic value, is the underlying worth of IMAB Old Company, which is reflected in its stock price. It is based on IMAB Old's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of IMAB Old's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of IMAB Old helps investors to forecast how IMAB stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of IMAB Old more accurately as focusing exclusively on IMAB Old's fundamentals will not take into account other important factors: About IMAB Old Valuation
The delisted stock valuation mechanism determines IMAB Old's current worth on a weekly basis. Our valuation model uses a comparative analysis of IMAB Old. We calculate exposure to IMAB Old's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of IMAB Old's related companies.I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. The company was founded in 2014 and is headquartered in Shanghai, the Peoples Republic of China. I-Mab ADR operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 378 people.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in IMAB Stock
If you are still planning to invest in IMAB Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the IMAB Old's history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |